We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGNY icon
176
Progyny
PGNY
$2.2B
$2.06M 0.12%
52,483
-198
-0.4% -$7.15K
BOOM icon
177
DMC Global
BOOM
$157M
$2.04M 0.12%
114,624
-14,822
-11% -$268K
HLX icon
178
Helix Energy Solutions
HLX
$1.41B
$2.03M 0.12%
275,148
+55,963
+26% +$398K
STKS icon
179
The ONE Group
STKS
$53M
$1.93M 0.11%
+263,044
New +$2M
ZUMZ icon
180
Zumiez
ZUMZ
$339M
$1.91M 0.11%
114,531
-13,146
-10% -$220K
TCBK icon
181
TriCo Bancshares
TCBK
$1.83B
$1.86M 0.11%
56,030
-7,076
-11% -$252K
SHYF
182
DELISTED
The Shyft Group
SHYF
$1.83M 0.1%
83,030
-10,170
-11% -$239K
CSCO icon
183
Cisco
CSCO
$479B
$1.8M 0.1%
34,829
-100
-0.3% -$4.92K
XPOF icon
184
Xponential Fitness
XPOF
$211M
$1.79M 0.1%
103,642
-67,194
-39% -$1.9M
JOUT icon
185
Johnson Outdoors
JOUT
$505M
$1.77M 0.1%
28,867
-3,611
-11% -$216K
ANGO icon
186
AngioDynamics
ANGO
$649M
$1.75M 0.1%
+168,069
New +$1.62M
FNKO icon
187
Funko
FNKO
$328M
$1.73M 0.1%
160,131
-21,332
-12% -$235K
SWI
188
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.68M 0.1%
163,855
-904
-0.5% -$8.24K
JNJ icon
189
Johnson & Johnson
JNJ
$625B
$1.66M 0.09%
10,027
-91
-0.9% -$14.7K
UPLD icon
190
Upland Software
UPLD
$15.4M
$1.59M 0.09%
44,181
+1,788
+4% +$61.6K
RCKT icon
191
Rocket Pharmaceuticals
RCKT
$394M
$1.57M 0.09%
78,986
+3,311
+4% +$66.9K
CLFD icon
192
Clearfield
CLFD
$374M
$1.56M 0.09%
32,862
-3,714
-10% -$159K
TRNS icon
193
Transcat
TRNS
$871M
$1.54M 0.09%
+18,084
New +$1.54M
BWXT icon
194
BWX Technologies
BWXT
$15.6B
$1.45M 0.08%
20,191
-15,062
-43% -$984K
SIMO icon
195
Silicon Motion
SIMO
$8.68B
$1.43M 0.08%
19,929
-87,492
-81% -$5.59M
MIRM icon
196
Mirum Pharmaceuticals
MIRM
$6.14B
$1.41M 0.08%
54,454
+2,159
+4% +$57.4K
CW icon
197
Curtiss-Wright
CW
$25.5B
$1.34M 0.08%
7,270
-5,039
-41% -$859K
ZBH icon
198
Zimmer Biomet
ZBH
$18.4B
$1.33M 0.08%
9,159
-6,020
-40% -$818K
TTD icon
199
Trade Desk
TTD
$6.49B
$1.33M 0.08%
17,241
-705
-4% -$47.7K
PBYI icon
200
Puma Biotechnology
PBYI
$454M
$1.31M 0.07%
371,034
+3,537
+1% +$11K

Similar funds

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.